India's pharma stocks fall as Trump outlines steep tariffs on generic drug imports
22/07/2026 05:24
BUZZ-India's pharma stocks fall as Trump outlines steep tariffs on generic drug imports ** India's pharma stocks fall in morning trading
** U.S. President Donald Trump says imported generic drugs will remain tariff-free for two years from August 1, before tariffs increase to 100% for one year and 200% thereafter
** Nifty Pharma Index .NIPHARM down 1.01% amid a 0.7% decline in Nifty 50 Index .NSEI
** Shares of Aurobindo Pharma ARBN.NS down 2.9%, Sun Pharmaceutical SUN.NS down 1.2%, Cipla CIPL.NS down 2%, Lupin LUPN.NS falls 3%, Glenmark Pharmaceuticals GLEN.NS dips 2.6%
** Shares of Dr. Reddy's Laboratories REDY.NS fall 1.4%, Zydus Lifesciences ZYDU.NS down 2.4% and Torrent Pharmaceuticals TORP.NS down 0.8%
(Reporting by Abhinav Parmar in Bengaluru)
Recent news on Dr. Reddy's Laboratories
See all newsDr Reddy's rolls out new generic Ozempic brands to ease Obeda supply hit
Dr Reddy's beats quarterly profit estimate on India market lift (updated)
India's Dr Reddy's beats quarterly profit estimate
Brief: Dr. Reddy's Q2 Consol Net PAT 9.25 Billion Rupees
Dr Reddy's rolls out new generic Ozempic brands amid Obeda supply disruption